The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Yubo International Biotech's current ratio for the quarter that ended in Mar. 2024 was 0.21.
Yubo International Biotech has a current ratio of 0.21. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Yubo International Biotech has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Yubo International Biotech's Current Ratio or its related term are showing as below:
YBGJ'
s Current Ratio Range Over the Past 10 Years
Min: 0.21 Med: 0.27 Max: 1.49
Current: 0.21
During the past 4 years, Yubo International Biotech's highest Current Ratio was 1.49. The lowest was 0.21. And the median was 0.27.
YBGJ's Current Ratio is ranked worse than 96.32% of 869
companies
in the Medical Devices & Instruments industry
Industry Median: 2.66
vs YBGJ: 0.21
Yubo International Biotech Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Yubo International Biotech's Current Ratio
For the Medical Instruments & Supplies subindustry, Yubo International Biotech's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yubo International Biotech's Current Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Yubo International Biotech's Current Ratio distribution charts can be found below:
* The bar in red indicates where Yubo International Biotech's Current Ratio falls into.
Yubo International Biotech Current Ratio Calculation
The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yubo International Biotech (OTCPK:YBGJ) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Yubo International Biotech Current Ratio Related Terms
Thank you for viewing the detailed overview of Yubo International Biotech's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Yubo International Biotech (Yubo International Biotech) Business Description
Yubo International Biotech Ltd is a technology company focused on the research and development and application of endometrial stem cells. It offers products and services under the brand VIVCELL. Its product offerings include healthcare products for the respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products. It also offers stem cell-related services including cell testing and health management consulting services. The company derives its revenue from the sale of nebulizers containing frozen tubes with medical fluid and from the sale of oral liquids health products. The nebulizers are sold directly to consumers on its online e-commerce platform.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
YBGJ has been successfully added to your 